Oral Aripiprazole Is an Effective Maintenance Treatment in Adolescents with Schizophrenia: A Randomized, Double-blind, Placebo-controlled Trial

被引:0
|
作者
Correll, Christoph U. [1 ]
Kohegyi, Eva [1 ]
Zhao, Cathy [1 ]
Baker, Ross A. [1 ]
McQuade, Robert [1 ]
Salzman, Phyllis [1 ]
Sanchez, Raymond [1 ]
Nyilas, Margaretta [1 ]
Carson, William [1 ]
机构
[1] Hofstra North Shore LIJ Sch Med, Zucker Hillside Hosp, Glen Oaks, NY USA
关键词
aripiprazole; maintenance treatment; pediatric; schizophrenia;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
T90
引用
收藏
页码:S349 / S350
页数:2
相关论文
共 50 条
  • [1] Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial
    Coffin, Phillip Oliver
    Santos, Glenn-Milo
    Das, Moupali
    Santos, Deirdre M.
    Huffaker, Shannon
    Matheson, Tim
    Gasper, James
    Vittinghoff, Eric
    Colfax, Grant N.
    ADDICTION, 2013, 108 (04) : 751 - 761
  • [2] Once-daily Oral Aripiprazole for Treatment of Tics in Children and Adolescents with Tourette's Disorder: A Randomized, Double-blind, Placebo-controlled Trial
    Sallee, Floyd R.
    Kohegyi, Eva
    Zhao, Joan
    McQuade, Robert
    Cox, Kevin
    Sanchez, Raymond
    Nyilas, Margaretta
    Carson, William
    Kurlan, Roger
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S378 - S379
  • [3] Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents
    Sallee, Floyd
    Kohegyi, Eva
    Zhao, Joan
    McQuade, Robert
    Cox, Kevin
    Sanchez, Raymond
    van Beek, Alet
    Nyilas, Margaretta
    Carson, William
    Kurlan, Roger
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (09) : 771 - 781
  • [4] Lovastatin for the adjunctive treatment of schizophrenia: A preliminary randomized double-blind placebo-controlled trial
    Ghanizadeh, Ahmad
    Rezaee, Zahra
    Dehbozorgi, Sara
    Berk, Michael
    Akhondzadeh, Shahin
    PSYCHIATRY RESEARCH, 2014, 219 (03) : 431 - 435
  • [5] Trimethoprim as Adjuvant Treatment in Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
    Shibre, Teshome
    Alem, Atalay
    Abdulahi, Abdulreshid
    Araya, Mesfin
    Beyero, Teferra
    Medhin, Girmay
    Deyassa, Negusse
    Negash, Alemayehu
    Nigatu, Alemayehu
    Kebede, Derege
    Fekadu, Abebaw
    SCHIZOPHRENIA BULLETIN, 2010, 36 (04) : 846 - 851
  • [6] Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study
    Muscatello, Maria Rosaria A.
    Bruno, Antonio
    Pandolfo, Gianluca
    Mico, Umberto
    Scimeca, Giuseppe
    Di Nardo, Floriana
    Santoro, Vincenza
    Spina, Edoardo
    Zoccali, Rocco A.
    SCHIZOPHRENIA RESEARCH, 2011, 127 (1-3) : 93 - 99
  • [7] Olanzapine Versus Placebo in Adolescents With Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Trial
    Kryzhanovskaya, Ludmila
    Schulz, S. Charles
    McDougle, Christopher
    Frazier, Jean
    Dittmann, Ralf
    Robertson-Plouch, Carol
    Bauer, Theresa
    Xu, Wen
    Wang, Wei
    Carlson, Janice
    Tohen, Mauricio
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2009, 48 (01) : 60 - 70
  • [8] Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial
    Fleischhacker, W. Wolfgang
    Heikkinen, Martti E.
    Olie, Jean-Pierre
    Landsberg, Wally
    Dewaele, Patricia
    McQuade, Robert D.
    Loze, Jean-Yves
    Hennicken, Delphine
    Kerselaers, Wendy
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (08) : 1115 - 1125
  • [9] A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
    Tandon, Rajiv
    Cucchiaro, Josephine
    Phillips, Debra
    Hernandez, David
    Mao, Yongcai
    Pikalov, Andrei
    Loebel, Antony
    JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (01) : 69 - 77
  • [10] The Impact of Eszopiclone Insomnia Treatment on Cognition in Schizophrenia: A Double-blind, Randomized, Placebo-controlled Trial
    Tek, Cenk
    Palmese, Laura B.
    Krystal, Andrew D.
    DeGeorge, Pamela C.
    Reutenauer, Erin L.
    Guloksuz, Sinan
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 341S - 342S